Personal information

Verified email domains

HIV-1 Vaccines, HIV-1 monoclonal antibodies
India

Biography

I am currently working as a Research Associate at the All India Institute of Medical Sciences (AIIMS), New Delhi, India. My primary expertise is in the design and development of HIV-1 vaccines, with a focus on monoclonal antibody discovery. I have specialized experience in designing and testing nanoparticle-based HIV-1 vaccines in preclinical animal models. My research aims to advance the understanding and effectiveness of vaccines against HIV-1, leveraging innovative approaches in vaccine delivery systems and immune response enhancement.

Activities

Employment (3)

All-India Institute of Medical Sciences: New Delhi, New Delhi, IN

2023-12-01 to present | Research Associate (Biochemistry)
Employment
Source: Self-asserted source
S. Singh

All India Institute of Medical Sciences: New Delhi, IN

2018-11-01 to 2023-11-30 | Ph.D. Scholar (Biochemistry)
Employment
Source: Self-asserted source
S. Singh

AMC: Amsterdam, NL

2023-07-17 to 2023-10-09 | Visiting Fellow (MEDICAL MICROBIOLOGY & INFECTION PREVENTION)
Employment
Source: Self-asserted source
S. Singh

Education and qualifications (1)

All-India Institute of Medical Sciences: New Delhi, New Delhi, IN

2018-11-15 to 2023-11-14 | Ph.D. (Biochemistry)
Education
Source: Self-asserted source
S. Singh

Professional activities (5)

Science Publishing Group: New York, US

2024-12-25 to present | Reviewer (International Journal of Immunology)
Service
Source: Self-asserted source
S. Singh

Springer Nature (Germany): Berlin, DE

2024-12-13 to present | Reviewer (Scientific Reports)
Service
Source: Self-asserted source
S. Singh

American Society for Microbiology: Washington, US

2024-12-19 to 2026-12-18 | Global Outreach - Postdoctoral Member
Membership
Source: Self-asserted source
S. Singh

International AIDS Society: Geneva, CH

2024-06-20 to 2026-06-19
Membership
Source: Self-asserted source
S. Singh

International AIDS Vaccine Initiative: New York, US

2024-01-19 to 2024-11-05 | Leadership Development Program (IAVI-LDP Cohort 3 )
Membership
Source: Self-asserted source
S. Singh

Funding (2)

Presenting native like trimeric HIV-1 C envelopes on invitro self-assembling protein Nanoparticles

2023-07 to 2023-10 | Award
HIV Research Trust (Macclesfield, GB)
Source: Self-asserted source
S. Singh

Council of Scientific & Industrial Research- Senior Research Fellow

2020-12 to 2030-11 | Salary award
Council of Scientific and Industrial Research, India (New Delhi, IN)
Source: Self-asserted source
S. Singh

Works (12)

The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms

Vaccines
2025-01-22 | Journal article
Contributors: Sanjeev Kumar; Iván del Moral-Sánchez; Swarandeep Singh; Maddy L. Newby; Joel D. Allen; Tom P. L. Bijl; Yog Vaghani; Liang Jing; Rakesh Lodha; Eric A. Ortlund et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms

2024-09-19 | Preprint
Contributors: Sanjeev Kumar; Iván del Moral-Sánchez; Swarandeep Singh; Maddy L. Newby; Joel D. Allen; Tom P. L. Bijl; Yog Vaghani; Liang Jing; Eric A. Ortlund; Max Crispin et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Erratum: Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody (iScience (2023) 26(9), (S2589004223016565), (10.1016/j.isci.2023.107579))

iScience
2023 | Journal article
EID:

2-s2.0-85174714479

Part of ISSN: 25890042
Contributors: Kumar, S.; Singh, S.; Chatterjee, A.; Bajpai, P.; Sharma, S.; Katpara, S.; Bhakhri, H.; Lodha, R.; Dutta, S.; Luthra, K.
Source: Self-asserted source
S. Singh via Scopus - Elsevier

Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody

bioRxiv
2023 | Other
EID:

2-s2.0-85171600062

Part of ISSN: 26928205
Contributors: Kumar, S.; Singh, S.; Chatterjee, A.; Bajpai, P.; Sharma, S.; Katpara, S.; Lodha, R.; Dutta, S.; Luthra, K.
Source: Self-asserted source
S. Singh via Scopus - Elsevier

Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody

iScience
2023 | Journal article
EID:

2-s2.0-85168611484

Part of ISSN: 25890042
Contributors: Kumar, S.; Singh, S.; Chatterjee, A.; Bajpai, P.; Sharma, S.; Katpara, S.; Lodha, R.; Dutta, S.; Luthra, K.
Source: Self-asserted source
S. Singh via Scopus - Elsevier
grade
Preferred source (of 2)‎

An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1

ACS Omega
2023-02-28 | Journal article
Part of ISSN: 2470-1343
Part of ISSN: 2470-1343
Contributors: Sanjeev Kumar; Swarandeep Singh; Kalpana Luthra
Source: Self-asserted source
S. Singh
grade
Preferred source (of 2)‎

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma

PLoS Pathogens
2021 | Journal article
EID:

2-s2.0-85116017859

Part of ISSN: 15537374 15537366
Contributors: Mishra, N.; Kumar, S.; Singh, S.; Bansal, T.; Jain, N.; Saluja, S.; Kumar, R.; Bhattacharyya, S.; Palanichamy, J.K.; Mir, R.A. et al.
Source: Self-asserted source
S. Singh via Scopus - Elsevier
grade
Preferred source (of 2)‎

The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41

International Immunopharmacology
2021-12 | Journal article
Part of ISSN: 1567-5769
Contributors: Reshma Perween; Murugavelu PraveenKumar; Tripti Shrivastava; Hilal Ahmed Parray; Vanshika Singh; Swarandeep Singh; Adarsh Chiranjivi; Kamini Jakhar; Sudipta Sonar; Mahima Tiwari et al.
Source: Self-asserted source
S. Singh
grade
Preferred source (of 2)‎

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus

International Immunopharmacology
2021-10 | Journal article
Part of ISSN: 1567-5769
Contributors: Praveenkumar Murugavelu; Reshma Perween; Tripti Shrivastava; Vanshika Singh; Hilal Ahmad Parray; Swarandeep Singh; Adarsh Kumar Chiranjivi; Ramachandran Thiruvengadam; Savita Singh; Naveen Yadav et al.
Source: Self-asserted source
S. Singh
grade
Preferred source (of 2)‎

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma

bioRxiv
2020 | Other
EID:

2-s2.0-85099865372

Part of ISSN: 26928205
Contributors: Mishra, N.; Kumar, S.; Singh, S.; Bansal, T.; Jain, N.; Saluja, S.; Palanichamy, J.K.; Mir, R.A.; Sinha, S.; Luthra, K.
Source: Self-asserted source
S. Singh via Scopus - Elsevier

Plasma neutralizing antibodies in an infant with interclade HIV-1 superinfection preferentially neutralize superinfecting HIV-1 strains

2020-12-11 | Preprint
Contributors: Nitesh Mishra; Shaifali Sharma; Ayushman Dobhal; Sanjeev Kumar; Himanshi Chawla; Swarandeep Singh; Ravinder Singh; Bimal Kumar Das; Rakesh Lodha; Sushil Kumar Kabra et al.
Source: Self-asserted source
S. Singh
grade
Preferred source (of 2)‎

Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.

The Journal of general virology
2020-09-11 | Journal article
Source: Self-asserted source
S. Singh
grade
Preferred source (of 2)‎